U.S. Markets closed

BioTime, Inc. (BTX)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
2.80+0.01 (+0.36%)
At close: 3:59PM EDT
People also watch
Full screen
Previous Close2.79
Bid0.00 x 0
Ask0.00 x 0
Day's Range2.75 - 2.81
52 Week Range2.47 - 4.01
Avg. Volume270,698
Market Cap324.25M
PE Ratio (TTM)4.71
EPS (TTM)0.6
Earnings DateNov 1, 2017 - Nov 6, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.17
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to BioTime, Inc. : September 22, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to BioTime, Inc. Here are 5 ETFs with the largest exposure to BTX-US. Comparing the performance and risk of BioTime, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ACCESSWIRE3 days ago

    BioTime - A Multi-Faceted Regenerative Medicine Company

    BEND, OR / ACCESSWIRE / September 22, 2017 / BioTime, Inc. (NASDAQ: BTX ), Sylva International has always been extremely interested in regenerative medicines because they've shown tremendous promise in ...

  • BioTime, Inc. :BTX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017
    Capital Cube3 days ago

    BioTime, Inc. :BTX-US: Earnings Analysis: Q2, 2017 By the Numbers : September 21, 2017

    Categories: Yahoo FinanceGet free summary analysis BioTime, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of BioTime, Inc. – Microbot Medical Inc, Baxter International Inc., Geron Corporation, PDL BioPharma, Inc., Omeros Corporation, Momenta Pharmaceuticals, Inc., Sanofi Sponsored ADR, Genetic Technologies Limited Sponsored ADR, Teva Pharmaceutical ... Read more (Read more...)